These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells. Murakami T; Inagaki N; Kondoh H Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205 [TBL] [Abstract][Full Text] [Related]
3. L-Carnitine inhibits the senescence-associated secretory phenotype of aging adipose tissue by JNK/p53 pathway. Yang LW; Song M; Li YL; Liu YP; Liu C; Han L; Wang ZH; Zhang W; Xing YQ; Zhong M Biogerontology; 2019 Apr; 20(2):203-211. PubMed ID: 30519860 [TBL] [Abstract][Full Text] [Related]
4. Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Kalinkovich A; Livshits G Ageing Res Rev; 2017 May; 35():200-221. PubMed ID: 27702700 [TBL] [Abstract][Full Text] [Related]
5. Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Palmer AK; Xu M; Zhu Y; Pirtskhalava T; Weivoda MM; Hachfeld CM; Prata LG; van Dijk TH; Verkade E; Casaclang-Verzosa G; Johnson KO; Cubro H; Doornebal EJ; Ogrodnik M; Jurk D; Jensen MD; Chini EN; Miller JD; Matveyenko A; Stout MB; Schafer MJ; White TA; Hickson LJ; Demaria M; Garovic V; Grande J; Arriaga EA; Kuipers F; von Zglinicki T; LeBrasseur NK; Campisi J; Tchkonia T; Kirkland JL Aging Cell; 2019 Jun; 18(3):e12950. PubMed ID: 30907060 [TBL] [Abstract][Full Text] [Related]
6. JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Xu M; Tchkonia T; Ding H; Ogrodnik M; Lubbers ER; Pirtskhalava T; White TA; Johnson KO; Stout MB; Mezera V; Giorgadze N; Jensen MD; LeBrasseur NK; Kirkland JL Proc Natl Acad Sci U S A; 2015 Nov; 112(46):E6301-10. PubMed ID: 26578790 [TBL] [Abstract][Full Text] [Related]
7. Changes in adipose tissue cellular composition during obesity and aging as a cause of metabolic dysregulation. Martyniak K; Masternak MM Exp Gerontol; 2017 Aug; 94():59-63. PubMed ID: 27939445 [TBL] [Abstract][Full Text] [Related]
8. Mechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue. Saxton SN; Clark BJ; Withers SB; Eringa EC; Heagerty AM Physiol Rev; 2019 Oct; 99(4):1701-1763. PubMed ID: 31339053 [TBL] [Abstract][Full Text] [Related]
9. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ. Calabro P; Yeh ET Subcell Biochem; 2007; 42():63-91. PubMed ID: 17612046 [TBL] [Abstract][Full Text] [Related]
10. Parallels in Immunometabolic Adipose Tissue Dysfunction with Ageing and Obesity. Trim W; Turner JE; Thompson D Front Immunol; 2018; 9():169. PubMed ID: 29479350 [TBL] [Abstract][Full Text] [Related]